NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today introduced VEVYE® Access for All, a groundbreaking initiative that underscores Harrow’s long‑standing commitment to acces…
Category: Business
RetinaLogik Secures $1.1M in Funding and Health Canada Class II Approval, Advancing the Future of Eye Care
CALGARY, Alberta–(BUSINESS WIRE)–RetinaLogik Inc., a Calgary-based startup, is proud to announce it has successfully completed a $1.1 million funding round and has received Health Canada’s Class II medical device approval for its cutting-edge technol…
GenSight Biologics annonce des communications scientifiques sur LUMEVOQ® au Congrès 2025 du NANOS
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour les maladies neurod…
GenSight Biologics Announces LUMEVOQ® Scientific Updates at NANOS 2025
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central …
Allergic Conjunctivitis Market Global Report and Competitive Analysis 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun Pharma, Teva – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Allergic Conjunctivitis Market Global Report Size and Share Analysis – Growth Trends and Forecast Report 2025-2033” report has been added to ResearchAndMarkets.com’s offering. The Allergic Conjunctivitis market is expected…
20/20 Onsite Receives Safety Excellence Award, Reinforcing Commitment to Unmatched Clinical Trial Support
BOSTON–(BUSINESS WIRE)–20/20 Onsite is proud to announce its recognition with the Safety Excellence Award by Whip Around.
Alcon to Host 2025 Capital Markets Day
GENEVA–(BUSINESS WIRE)–Alcon to Host 2025 Capital Markets Day
Alcon to Host 2025 Capital Markets Day
GENEVA–(BUSINESS WIRE)–Alcon to Host 2025 Capital Markets Day
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Topcon Healthcare, Inc., RadiusXR, and Glaukos Corporation (NYSE: GKOS) announced a new collaboration and the launch of RadiusXR’s new wearable vision testing platform – Inspire®. This collaboration unites RadiusXR…
Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced the execution of a five-year strategic supply and development (“SSD”) agreement for TRIESENCE® (triamcinolone acetoni…
NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it will hold a virtual Special Meeting on April 16, 2025, at which stockholders will vote on a proposal for the liquidation …
Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters
TORONTO–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the availability of expanded parameters for TOTAL30® for Astigmatism, the first and only monthly replacement Wat…
Alcon Canada renforce son engagement envers les patients atteints d’astigmatisme en offrant les lentilles cornéennes TOTAL30 pour l’astigmatisme dans de nouveaux paramètres élargis
TORONTO–(BUSINESS WIRE)–Alcon (SIX/NYSE : ALC), le chef de file mondial en matière de soins oculaires qui se consacre à aider les gens à voir avec clarté, a annoncé aujourd’hui l’ajout de paramètres élargis à la gamme de lentilles TOTAL30MD pour l’as…
STAAR Surgical Announces Leadership Transition
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced a leadership transition. Stephen C. Farr…
ForSight Robotics Achieves ISO 13485:2016 Certification
YOKNEAM ILLIT, Israel–(BUSINESS WIRE)– #ISOCertification–ForSight Robotics achieves ISO 13485:2016 certification, an international benchmark for quality management systems in the medical device industry.
Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
GENEVA–(BUSINESS WIRE)–Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
GENEVA–(BUSINESS WIRE)–Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
CDR-Life Announces Fifth Milestone Achievement with Boehringer Ingelheim in Geographic Atrophy
ZÜRICH–(BUSINESS WIRE)–CDR-Life today announced the achievement of the fifth milestone under its collaboration and licensing agreement with Boehringer Ingelheim in the advancement of BI 771716, a novel therapeutic candidate for the treatment of geogr…
EyeCare Partners Announces New Physician Leadership Appointments
ST. LOUIS–(BUSINESS WIRE)– #elevatingeyeare–EyeCare Partners (ECP) is pleased to announce the appointment of Michael Nordlund, M.D., Ph.D., as Chief Medical Officer (CMO) and Joseph Gira, M.D., as Chief Physician Relations Officer (CPRO), strengthen…
Seonix Bio Announces US Launch of SightScore, the First Commercially Available Clinical Polygenic Risk Score Testing Service for Glaucoma
SAN DIEGO–(BUSINESS WIRE)–Seonix Bio, a leader in the development of genetic testing for glaucoma, today announced the U.S. launch of SightScore, the first commercially available clinical polygenic risk score testing service for primary open-angle gl…